Investigation of usability and efficacy of loratadine rapidly disintegrating tablets (Claritin® Reditabs®)

Masutaka Furue, Shinichi Imafuku

Research output: Contribution to journalReview article

Abstract

A questionnaire survey on the usability and efficacy of loratadine rapidly disintegrating tablets (Claritin® Reditabs®) was conducted in 64 patients with pruritic skin disease (17 with urticaria, 25 with atopic dermatitis, and 22 with other eczema/dermatitis). Regarding overall ease of ingestion, 54 patients (84.4%) considered it "good", 9 (14.1%) "neither good nor bad", and 0 (0%) "bad". Eleven patients (17.2%) sometimes "forgot to take" the drug and 53 (82.8%) did not forget to take the drug, with a significantly lower number of patinets "forgetting to take" the drug. Fifty-four patients (84.4%) stated that they wanted to continue the drug. The reasons for wanting to continue it (with multiple answers allowed) included "it is convenient to take the drug anywhere" for 28 patients (43.8%), "no need for water" for 25 (39.1%), and "once-daily ingestion" for 23 (35.9%). It was found that the rapidly disintegrating tablet dosage form improved drug compliance.

Original languageEnglish
Pages (from-to)195-198
Number of pages4
JournalNishinihon Journal of Dermatology
Volume68
Issue number2
DOIs
Publication statusPublished - May 29 2006

    Fingerprint

All Science Journal Classification (ASJC) codes

  • Dermatology

Cite this